• Targos projectmanagement Team and Targos building

  • Targos Lab Team

  • Targos Logistics Team

  • Targos Advance Team

  • Targos Study Office Team

  • Targos employees and Targos building

  • Expert Training by Targos

  • Expert Training - microscope room

Targos - A Leader in Biomarker Services for more than 10 years

Targos GmbH building and staff 2015

Targos core service business is to provide highly standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industry.

The company has supported more than 400 international clinical trials since 2005, which have led to the successful approval of several targeted therapies and IVDs for our customers.

The expert team of on-site clinical pathologists operates in a professional environment of project management, logistics, data and quality management. Targos also supports the introduction of new Companion Diagnostic assays into the market.

Targos is a fully GCP-compliant central laboratory that is inspected by the U.S. Food and Drug Administration (FDA). Since 2014 Targos Molecular Pathology GmbH is accredited by the College of American Pathologists and the US-CLIA program.

Targos News

31st European Congress of Pathology - Pathology is Nice

September 7 - 11 , 2019 | Nice, France

31st European Congress of Pathology - Pathology is Nice

Poster Presentations

1.  Standardised structured training of pathologists to improve inter- and intra-reader reproducibility for scoring PD-L1 expression levels in non-small cell lung cancer: results of a worldwide training programme.

2. Digital microscopy - is there a need for standardisation?
3. High reproducibility of PD-L1 scoring among pathologists participating in live trainings.
»Read more

Oral Presentations

Prof. Reinhard Büttner:
• Genomic profiling for driver mutations in cancer: NTRK gene fusions (Bayer)
• LS-09 From respectable to exceptional: advancing beyond existing PD-L1 test capabilities for histologic and cytologic NSCLC specimens (AstraZeneca)
Prof. Bharat Jasani:
• Strategies for addressing the intrinsic source of error associated with PD-L1 scoring and interpretation
»Read more